Quantcast

Latest National Eye Institute Stories

Time For An Eye Exam During Healthy Vision Month
2013-04-30 18:51:06

Lee Rannals for redOrbit.com — Your Universe Online May is being promoted as the Healthy Vision Month, and many organizations are using it as a way to encourage people to get their eyes checked. Healthy Vision Month and the Centers for Disease Control and Prevention´s Vision Health Initiative (VHI) are partnering with the National Eye Institute (NEI) during May to encourage all Americans to make vision a health priority. According to the CDC, the number of Americans 40 years...

Image Credit: Photos.com
2012-05-02 08:50:45

Image Credit: Photos.com --- Connie K. Ho for RedOrbit.com Mark your calendars: May is Healthy Vision Month. Since 2003, the National Eye Institute (NEI) has promoted May with this national eye health observance. During Health Vision Month, NEI hopes to increase awareness about early diagnosis and treatment of vision loss. The NEI, under the National Institute of Health (NIH), helps develop the federal government´s research on the visual system and eye diseases. The NIH is...

2012-01-05 11:48:44

Glaucoma is a major cause of vision loss in the United States, affecting about 2.2 million Americans. The National Eye Institute (NEI) leads research toward better prevention, detection, and treatment of this often silent but devastating disease. During Glaucoma Awareness Month, NEI highlights research advances, showcases education and awareness efforts, and reminds Americans that early detection and treatment is the best way to prevent vision loss. NEI advises all Americans at risk of...

2011-11-04 21:14:14

Diabetic retinopathy is one of the most common and debilitating complications of diabetes. During National Diabetes Month, the National Eye Institute (NEI), a part of the National Institutes of Health, is encouraging people with diabetes to get annual dilated eye exams and take steps to avoid vision loss. About 28.5 percent of U.S. adults age 40 and older with diabetes have diabetic retinopathy, a condition that causes blood vessels of the retina to swell and leak fluid. The retina is the...

2011-10-25 07:00:00

New Vision Protecting Product, Vita Vision is Launched by South Florida Vitamin Company Vitalmax Vitamins Delray Beach, FL (PRWEB) October 25, 2011 Board certified anti-aging doctor, Mark Rosenbergâs groundbreaking research has found a combination of ingredients that offers an alternative to declining vision. Dr. Rosenberg and Vitalmax Vitamins introduces Vita Vision, a proprietary supplement that has powerful antioxidants and a carefully balanced blend of ingredients like...

2011-10-13 20:46:02

Older people are at increased risk of several eye diseases, including age-related macular degeneration (AMD), cataracts, and glaucoma. AMD can cause profound loss of central vision due to the breakdown of the eye's light-sensing cells in the retina. Cataracts cloud vision through clumping of proteins in the eye's lens. Glaucoma damages the optic nerve often due to increased pressure in the eye. The increase in type 2 diabetes, which is more common in older Americans and especially minorities,...

2011-05-20 12:00:00

MECHANICSBURG, Pa., May 20, 2011 /PRNewswire-USNewswire/ -- Millions of people in the United States have undetected vision problems and eye conditions. The Pennsylvania Association for the Blind (PAB) along with the National Eye Institute (NEI) needs your help by encouraging people in your community, friends and family to schedule eye exams. Through a comprehensive dilated eye exam, eyecare professionals can detect common vision problems and eye disease, many of which have no early...

2011-04-28 21:14:23

Researchers are reporting results from the first year of a two-year clinical trial that Avastin, a drug approved to treat some cancers and that is commonly used off-label to treat age-related macular degeneration (AMD), is as effective as the Food and Drug Administration-approved drug Lucentis for the treatment of AMD. The report, from the Comparison of AMD Treatments Trials (CATT), was published online today in the New England Journal of Medicine. CATT is funded by the National Eye Institute...

2011-04-28 11:48:00

CLEVELAND, April 28, 2011 /PRNewswire/ -- A new study published online today in The New England Journal of Medicine (NEJM) shows bevacizumab (Avastin) is as effective as ranibizumab (Lucentis), the current Food and Drug Administration-approved drug for treating age-related macular degeneration (AMD). The results are from the landmark "Comparison of AMD Treatments Trials" (CATT) study, a pioneering comparative effectiveness trial made possible through funding by the National Eye...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related